Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose–response meta-analysis.
Purpose: Aspirin has been suggested to reduce the risk of cancer. However, previous studies have been inconsistent regarding the relationship between aspirin use and the risk of occurrence of hepatocellular carcinoma (HCC). The purpose of this study was to assess the effect of aspirin on clinical ou...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 79; no. 1; pp. 39 - 62 |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Springer Nature
Jan2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |